Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

CM Alvim Impl Ti 4.3X8: medical device reports filed with FDA

1,525 reports name it, 2019–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

1,525
device reports naming the brand
0% of all MAUDE reports · about 218 a year
162
reports, 12 months to August 2026
243 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0.1%
classified as death, as reported
1 reports · not verified by FDA

FDA's MAUDE database holds 1,525 reports that name the brand "CM Alvim Impl Ti 4.3X8" (endosseous dental implant), received between July 2019 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

162 reports arrived in the 12 months to August 2026, down 33% from 243 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.9%) and death (0.1%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (84.1%), loss of osseointegration (9.1%) and fracture (0.6%). The patient problems coded most often are pain, fibrosis and swelling/ edema. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

080160Sep 2021: 4Oct 2021: 6Nov 2021: 6Dec 2021: 62022Jan 2022: 8Feb 2022: 2Mar 2022: 9Apr 2022: 12May 2022: 24Jun 2022: 25Jul 2022: 13Aug 2022: 64Sep 2022: 34Oct 2022: 108Nov 2022: 46Dec 2022: 122023Jan 2023: 137Feb 2023: 16Mar 2023: 36Apr 2023: 73May 2023: 11Jun 2023: 11Jul 2023: 3Aug 2023: 29Sep 2023: 10Oct 2023: 21Nov 2023: 20Dec 2023: 42024Jan 2024: 6Feb 2024: 4Mar 2024: 0Apr 2024: 12May 2024: 16Jun 2024: 31Jul 2024: 57Aug 2024: 160Sep 2024: 75Oct 2024: 49Nov 2024: 20Dec 2024: 212025Jan 2025: 25Feb 2025: 10Mar 2025: 8Apr 2025: 1May 2025: 0Jun 2025: 24Jul 2025: 8Aug 2025: 2Sep 2025: 6Oct 2025: 21Nov 2025: 4Dec 2025: 342026Jan 2026: 30Feb 2026: 12Mar 2026: 9Apr 2026: 13May 2026: 5Jun 2026: 12Jul 2026: 15Aug 2026: 1

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02264512019: 520192020: 4620202021: 5520212022: 35720222023: 37120232024: 45120242025: 14320252026: 972026

Event type and report source

Event type, as classified on the report

Death0.1%1
Injury99.9%1,524
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report99.4%1,516
Voluntary report0%0
User facility report0%0
Distributor report0.6%9
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,28284.1%62.8%
Loss of osseointegration1399.1%22.4%
Fracturea broken bone90.6%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified976.4%
Fibrosis926%
Swelling/ edema402.6%
Tissue damage201.3%
Fistula181.2%
Inflammationinflammation90.6%
Sinus perforation90.6%
Hemorrhage/blood loss/bleeding60.4%
Hyperresponsive to stimuli60.4%
Abscessa collection of pus40.3%
Failure of implant10.1%
Hypersensitivity/allergic reaction10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureCM Alvim Impl Ti 4.3X8Product code DZEAll MAUDE reports
Reports1,5253,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports109
Classified as injury99.9%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer99.4%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about CM Alvim Impl Ti 4.3X8 reports

How many FDA reports name CM Alvim Impl Ti 4.3X8?

1,525 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 162 in the latest 12 months.

What kinds of events are reported?

injury (99.9%) and death (0.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (84.1%), loss of osseointegration (9.1%) and fracture (0.6%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (99.4%) and distributor reports (0.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that CM Alvim Impl Ti 4.3X8 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.